Center for Technology Transfer and Commercialization
Center for Technology Transfer & Commercialization breaks records in rapid facilitation of COVID-19 related agreements
Jul. 9, 2020—To keep pace with Vanderbilt researchers developing COVID-19 solutions, the Center for Technology Transfer & Commercialization has facilitated three license agreements, 11 patent applications and 43 material transfer agreements in record time.
Jan. 27, 2020—Vanderbilt's growth is intertwined with Nashville's, and the successes and challenges of both are shaped and reflected by the other, writes Interim Chancellor and Provost Susan R. Wente in her latest "Open Mind" column.
Oct. 21, 2019—Soldiers from the 3rd Brigade Combat Team of the 101st Airborne Division at Fort Campbell, Kentucky, and researchers at Vanderbilt's School of Engineering are building a partnership to identify and solve tactical problems with soldier-inspired solutions.
Jun. 7, 2019—Dave Owens, a management professor and expert on innovation, has been named the Evans Family Executive Director of the Wond’ry.
Nov. 2, 2018—Vanderbilt University—for the second consecutive year—has been named the 10th most innovative university in the world, according to a 2018 "Reuters Top 100" analysis.
Nov. 3, 2017—The new Leveraged Proposal Organization and Development program — L-POD — supports faculty as they pursue grants and funding opportunities to bolster the university's competitiveness in research funding.
Jun. 8, 2017—Last week, Vanderbilt’s Department of Radiology and Radiological Sciences hosted the inaugural RadX Innovation Challenge Pitch Event.
Nov. 7, 2016—Vanderbilt's Center for Technology Transfer and Commercialization and the Wond’ry are hosting a Flash Pitch competition for students. Similar to the popular television show "Shark Tank," participants will have 90 seconds to present their winning ideas to a panel of investors and entrepreneurship experts.
Oct. 22, 2015—A wireless electrocardiogram (ECG) system invented at Vanderbilt University and marketed by a Nashville company, InvisionHeart, has received U.S. Food and Drug Administration (FDA) approval.
Oct. 1, 2015—La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.
Apr. 16, 2015—A strategy for commercializing a potential new test for colon cancer that can make tumor cells “glow” won top honors at last week’s TechVenture Challenge.
Oct. 17, 2014—The professionals at Vanderbilt's Center for Technology Transfer and Commercialization are often asked, "What exactly is technology transfer?" A new video sums up what tech transfer does and why it matters.